article thumbnail

Embio Ltd. v. Malladi Drugs: Madras High Court Clarifies the Extent of Burden of Proof in Matters concerning Patent Revocation

SpicyIP

While the Court’s analysis touched upon multiple aspects of patentability and revocation, including ‘novelty,’ ‘inventive step,’ ‘non-obviousness’ and ‘person interested,’ the most significant point was related to the burden of proof in matters concerning patent revocation petitions. Thus, all three elements of ‘inventive step’ under s.

Invention 105
article thumbnail

Why Should You Patent Your Invention?

Intepat

A patent is a form of intellectual property right granted to an invention. It gives the inventor or patent owner exclusive rights and prevents others from manufacturing, selling, or marketing the invention. Patents are valuable assets that enable one to share their invention in public without any fear of being misused.

Invention 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Understanding IPO’s Rejection of UPL’s Patent Application for Mancozeb and Ortho Silicic Acid Combination in Light of the Patent Bargain and Sufficiency of Disclosure

SpicyIP

The essence of the patent regime lies in, the ‘patent bargain’ – inventors are granted a monopoly over their invention for a fixed term of 20 years in exchange for a complete disclosure. Under Section 10(4), an applicant is supposed to disclose the best method of performing the invention in the complete specification.

article thumbnail

[Guest Post] CJEU weighs in on supplementary protection certificates in Merck v Teva/Clonmel decision

The IPKat

Here's what Claudio and Federico have to say: Two Kats, hungry to hear the outcome of the two CJEU referrals, via the Public Domain Image Archive "In a long-awaited decision issued on 19 December 2024, the Court of Justice of the European Union ("CJEU") ruled on two joint cases ( C-119/22 and C-149/22 ).

article thumbnail

A Rare Invocation for a Rare Disease?: Government Urged to Invoke Section 100, Patents Act for Rare Disease Medicine

SpicyIP

Section 100 empowers the central government to use, or authorise to use, an invention (application or grant) for the purposes of the government, on a non-commercial basis. This includes but is not limited to using the invention in case of national emergency or other situations of extreme urgency. Another similar petition (Seba P.A

article thumbnail

Can We Patent An Idea That Made To Public?

Intepat

Will it affect the patentability of the invention? It is time to think if our ideas are patentable if we share them in the public domain. In other words, it calls the idea a lack of inventiveness. This can also occur as a consequence of sharing your ideas in the public domain. The solution.

article thumbnail

New SPC referral to the CJEU on the interpretation of Art 3(a) and (c) for combination products (Merck v Clonmel)

The IPKat

Furthermore, the primary inventive contribution of the patent was the disclosure of ezetimibe, and not its combined use with simvastatin. However, neither is it necessary that the product in some way corresponds to the "core inventive concept" of the patent.

Art 119